PubMed

Outcome of Patients with a Positive Sentinel Lymph Node who do not Undergo Completion Lymphadenectomy.

Kingham TP, Panageas KS, Ariyan CE, Busam KJ, Brady MS, Coit DG.

Ann Surg Oncol. 2009 Nov 19. [Epub ahead of print]PMID: 19924486 [PubMed - as supplied by publisher]Related articles

Prognosis and patterns of care in elderly patients with glioma.

Iwamoto FM, Reiner AS, Nayak L, Panageas KS, Elkin EB, Abrey LE.

Cancer. 2009 Aug 25;115(23):5534-5540. [Epub ahead of print]PMID: 19708033 [PubMed - as supplied by publisher]Related articles

Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response.

Rizzuto GA, Merghoub T, Hirschhorn-Cymerman D, Liu C, Lesokhin AM, Sahawneh D, Zhong H, Panageas KS, Perales MA, Altan-Bonnet G, Wolchok JD, Houghton AN.

J Exp Med. 2009 Apr 13;206(4):849-66. Epub 2009 Mar 30.PMID: 19332877 [PubMed - indexed for MEDLINE]Related articlesFree article

An increased number of sentinel lymph nodes is associated with advanced Breslow depth and lymphovascular invasion in patients with primary melanoma.

Schmidt CR, Panageas KS, Coit DG, Patel A, Brady MS.

Ann Surg Oncol. 2009 Apr;16(4):948-52. Epub 2009 Feb 5.PMID: 19194758 [PubMed - indexed for MEDLINE]Related articles

Patterns of care in elderly glioblastoma patients.

Iwamoto FM, Reiner AS, Panageas KS, Elkin EB, Abrey LE.

Ann Neurol. 2008 Dec;64(6):628-34.PMID: 19107984 [PubMed - indexed for MEDLINE]Related articles

Phase II trial of 17-allylamino-17-demethoxygeldanamycin in patients with metastatic melanoma.

Solit DB, Osman I, Polsky D, Panageas KS, Daud A, Goydos JS, Teitcher J, Wolchok JD, Germino FJ, Krown SE, Coit D, Rosen N, Chapman PB.

Clin Cancer Res. 2008 Dec 15;14(24):8302-7.PMID: 19088048 [PubMed - indexed for MEDLINE]Related articles

Sequential therapy with fludarabine, high-dose cyclophosphamide, and rituximab in previously untreated patients with chronic lymphocytic leukemia produces high-quality responses: molecular remissions predict for durable complete responses.

Lamanna N, Jurcic JG, Noy A, Maslak P, Gencarelli AN, Panageas KS, Heaney ML, Brentjens RJ, Golde DW, Scheinberg DA, Zelenetz AD, Weiss MA.

J Clin Oncol. 2009 Feb 1;27(4):491-7. Epub 2008 Dec 15.PMID: 19075280 [PubMed - indexed for MEDLINE]Related articles

A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer.

Dickler MN, Rugo HS, Eberle CA, Brogi E, Caravelli JF, Panageas KS, Boyd J, Yeh B, Lake DE, Dang CT, Gilewski TA, Bromberg JF, Seidman AD, D'Andrea GM, Moasser MM, Melisko M, Park JW, Dancey J, Norton L, Hudis CA.

Clin Cancer Res. 2008 Dec 1;14(23):7878-83.PMID: 19047117 [PubMed - indexed for MEDLINE]Related articles

Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible.

Dang C, D'Andrea G, Lake D, Sugarman S, Fornier M, Moynahan ME, Gilewski T, Hurria A, Mills N, Troso-Sandoval T, George R, Robson M, Dickler M, Smith K, Panageas KS, Norton L, Hudis CA.

Clin Breast Cancer. 2008 Oct;8(5):418-24.PMID: 18952555 [PubMed - indexed for MEDLINE]Related articles

Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma.

Perales MA, Yuan J, Powel S, Gallardo HF, Rasalan TS, Gonzalez C, Manukian G, Wang J, Zhang Y, Chapman PB, Krown SE, Livingston PO, Ejadi S, Panageas KS, Engelhorn ME, Terzulli SL, Houghton AN, Wolchok JD.

Mol Ther. 2008 Dec;16(12):2022-9. Epub 2008 Sep 16.PMID: 18797450 [PubMed - indexed for MEDLINE]Related articles

Treatment patterns and prognosis in patients with human immunodeficiency virus and primary central system lymphoma.

Kreisl TN, Panageas KS, Elkin EB, Deangelis LM, Abrey LE.

Leuk Lymphoma. 2008 Sep;49(9):1710-6.PMID: 18661394 [PubMed - indexed for MEDLINE]Related articles

Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy.

Ekenel M, Iwamoto FM, Ben-Porat LS, Panageas KS, Yahalom J, DeAngelis LM, Abrey LE.

Cancer. 2008 Sep 1;113(5):1025-31.PMID: 18618509 [PubMed - indexed for MEDLINE]Related articlesFree article

Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy.

Moore Dalal K, Zhou Q, Panageas KS, Brady MS, Jaques DP, Coit DG.

Ann Surg Oncol. 2008 Aug;15(8):2206-14. Epub 2008 May 30.PMID: 18512102 [PubMed - indexed for MEDLINE]Related articles

Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma.

Abbasi NR, Yancovitz M, Gutkowicz-Krusin D, Panageas KS, Mihm MC, Googe P, King R, Prieto V, Osman I, Friedman RJ, Rigel DS, Kopf AW, Polsky D.

Arch Dermatol. 2008 Apr;144(4):469-74.PMID: 18427040 [PubMed - indexed for MEDLINE]Related articlesFree article

Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up.

Tan LK, Giri D, Hummer AJ, Panageas KS, Brogi E, Norton L, Hudis C, Borgen PI, Cody HS 3rd.

J Clin Oncol. 2008 Apr 10;26(11):1803-9. Epub 2008 Mar 10.PMID: 18332473 [PubMed - indexed for MEDLINE]Related articles

How to build and interpret a nomogram for cancer prognosis.

Iasonos A, Schrag D, Raj GV, Panageas KS.

J Clin Oncol. 2008 Mar 10;26(8):1364-70. Review.PMID: 18323559 [PubMed - indexed for MEDLINE]Related articles

Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features.

Raizer JJ, Hwu WJ, Panageas KS, Wilton A, Baldwin DE, Bailey E, von Althann C, Lamb LA, Alvarado G, Bilsky MH, Gutin PH.

Neuro Oncol. 2008 Apr;10(2):199-207. Epub 2008 Feb 20.PMID: 18287337 [PubMed - indexed for MEDLINE]Related articlesFree article

Bcl-6 predicts improved prognosis in primary central nervous system lymphoma.

Levy O, Deangelis LM, Filippa DA, Panageas KS, Abrey LE.

Cancer. 2008 Jan 1;112(1):151-6.PMID: 17999414 [PubMed - indexed for MEDLINE]Related articlesFree article

Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma.

Wolchok JD, Yuan J, Houghton AN, Gallardo HF, Rasalan TS, Wang J, Zhang Y, Ranganathan R, Chapman PB, Krown SE, Livingston PO, Heywood M, Riviere I, Panageas KS, Terzulli SL, Perales MA.

Mol Ther. 2007 Nov;15(11):2044-50. Epub 2007 Aug 28.PMID: 17726460 [PubMed - indexed for MEDLINE]Related articles

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI).

Janetzki S, Panageas KS, Ben-Porat L, Boyer J, Britten CM, Clay TM, Kalos M, Maecker HT, Romero P, Yuan J, Kast WM, Hoos A; Elispot Proficiency Panel of the CVC Immune Assay Working Group.

Cancer Immunol Immunother. 2008 Mar;57(3):303-15. Epub 2007 Aug 25.PMID: 17721781 [PubMed - indexed for MEDLINE]Related articlesFree article

Patterns of treatment in older adults with primary central nervous system lymphoma.

Panageas KS, Elkin EB, Ben-Porat L, Deangelis LM, Abrey LE.

Cancer. 2007 Sep 15;110(6):1338-44.PMID: 17647247 [PubMed - indexed for MEDLINE]Related articlesFree article

When you look matters: the effect of assessment schedule on progression-free survival.

Panageas KS, Ben-Porat L, Dickler MN, Chapman PB, Schrag D.

J Natl Cancer Inst. 2007 Mar 21;99(6):428-32.PMID: 17374832 [PubMed - indexed for MEDLINE]Related articlesFree article

Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.

Taylor RC, Patel A, Panageas KS, Busam KJ, Brady MS.

J Clin Oncol. 2007 Mar 1;25(7):869-75.PMID: 17327608 [PubMed - indexed for MEDLINE]Related articles

Increased dose density is feasible: a pilot study of adjuvant epirubicin and cyclophosphamide followed by paclitaxel, at 10- or 11-day intervals with filgrastim support in women with breast cancer.

Fornier MN, Seidman AD, Lake D, D'Andrea G, Bromberg J, Robson M, Van Poznak C, Panageas KS, Atienza M, Norton L, Hudis C.

Clin Cancer Res. 2007 Jan 1;13(1):223-7.PMID: 17200358 [PubMed - indexed for MEDLINE]Related articlesFree article

Identifying and addressing barriers to the delivery of optimal therapy for primary central nervous system lymphoma in the broader community.

Abrey LE, Panageas KS.

Leuk Lymphoma. 2006 Dec;47(12):2449-52. Review.PMID: 17169791 [PubMed - indexed for MEDLINE]Related articles

Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model.

Abrey LE, Ben-Porat L, Panageas KS, Yahalom J, Berkey B, Curran W, Schultz C, Leibel S, Nelson D, Mehta M, DeAngelis LM.

J Clin Oncol. 2006 Dec 20;24(36):5711-5. Epub 2006 Nov 20.PMID: 17116938 [PubMed - indexed for MEDLINE]Related articles

YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas.

Hormigo A, Gu B, Karimi S, Riedel E, Panageas KS, Edgar MA, Tanwar MK, Rao JS, Fleisher M, DeAngelis LM, Holland EC.

Clin Cancer Res. 2006 Oct 1;12(19):5698-704.PMID: 17020973 [PubMed - indexed for MEDLINE]Related articlesFree article

Properties of analysis methods that account for clustering in volume-outcome studies when the primary predictor is cluster size.

Panageas KS, Schrag D, Russell Localio A, Venkatraman ES, Begg CB.

Stat Med. 2007 Apr 30;26(9):2017-35.PMID: 17016864 [PubMed - indexed for MEDLINE]Related articles

A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy.

Hurria A, Hurria A, Zuckerman E, Panageas KS, Fornier M, D'Andrea G, Dang C, Moasser M, Robson M, Seidman A, Currie V, VanPoznak C, Theodoulou M, Lachs MS, Hudis C.

J Am Geriatr Soc. 2006 Jul;54(7):1119-24.PMID: 16866685 [PubMed - indexed for MEDLINE]Related articles

Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort.

Elkin EB, Hurria A, Mitra N, Schrag D, Panageas KS.

J Clin Oncol. 2006 Jun 20;24(18):2757-64.PMID: 16782916 [PubMed - indexed for MEDLINE]Related articles

Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.

Hurria A, Rosen C, Hudis C, Zuckerman E, Panageas KS, Lachs MS, Witmer M, van Gorp WG, Fornier M, D'Andrea G, Moasser M, Dang C, Van Poznak C, Hurria A, Holland J.

J Am Geriatr Soc. 2006 Jun;54(6):925-31.PMID: 16776787 [PubMed - indexed for MEDLINE]Related articles

Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanoma.

Hwu WJ, Panageas KS, Menell JH, Lamb LA, Aird S, Krown SE, Williams LJ, Chapman PB, Livingston PO, Wolchok JD, Houghton AN.

Cancer. 2006 Jun 1;106(11):2445-51.PMID: 16639739 [PubMed - indexed for MEDLINE]Related articlesFree article

Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia.

Lamanna N, Kalaycio M, Maslak P, Jurcic JG, Heaney M, Brentjens R, Zelenetz AD, Horgan D, Gencarelli A, Panageas KS, Scheinberg DA, Weiss MA.

J Clin Oncol. 2006 Apr 1;24(10):1575-81. Epub 2006 Mar 6.PMID: 16520464 [PubMed - indexed for MEDLINE]Related articles

Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection.

Schrag D, Earle C, Xu F, Panageas KS, Yabroff KR, Bristow RE, Trimble EL, Warren JL.

J Natl Cancer Inst. 2006 Feb 1;98(3):163-71.PMID: 16449676 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours.

Van Poznak C, Cross SS, Saggese M, Hudis C, Panageas KS, Norton L, Coleman RE, Holen I.

J Clin Pathol. 2006 Jan;59(1):56-63.PMID: 16394281 [PubMed - indexed for MEDLINE]Related articlesFree article

Systemic high-dose intravenous methotrexate for central nervous system metastases.

Lassman AB, Abrey LE, Shah GD, Panageas KS, Begemann M, Malkin MG, Raizer JJ.

J Neurooncol. 2006 Jul;78(3):255-60. Erratum in: J Neurooncol. 2006 Jul;78(3):261. Shah, Gaurav G [corrected to Shah, Gaurav D]. PMID: 16344918 [PubMed - indexed for MEDLINE]Related articles

Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma.

Ben-Porat L, Panageas KS, Hanlon C, Patel A, Halpern A, Houghton AN, Coit D.

Cancer. 2006 Jan 1;106(1):163-71.PMID: 16331596 [PubMed - indexed for MEDLINE]Related articlesFree article

Variates of survival in metastatic uveal melanoma.

Rietschel P, Panageas KS, Hanlon C, Patel A, Abramson DH, Chapman PB.

J Clin Oncol. 2005 Nov 1;23(31):8076-80.PMID: 16258106 [PubMed - indexed for MEDLINE]Related articles

Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis.

Panageas KS, Elkin EB, DeAngelis LM, Ben-Porat L, Abrey LE.

Cancer. 2005 Dec 1;104(11):2466-72.PMID: 16240449 [PubMed - indexed for MEDLINE]Related articlesFree article

Delayed neurotoxicity in primary central nervous system lymphoma.

Omuro AM, Ben-Porat LS, Panageas KS, Kim AK, Correa DD, Yahalom J, Deangelis LM, Abrey LE.

Arch Neurol. 2005 Oct;62(10):1595-600.PMID: 16216945 [PubMed - indexed for MEDLINE]Related articlesFree article

Developing a cancer-specific geriatric assessment: a feasibility study.

Hurria A, Gupta S, Zauderer M, Zuckerman EL, Cohen HJ, Muss H, Rodin M, Panageas KS, Holland JC, Saltz L, Kris MG, Noy A, Gomez J, Jakubowski A, Hudis C, Kornblith AB.

Cancer. 2005 Nov 1;104(9):1998-2005.PMID: 16206252 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinicopathological features of and risk factors for multiple primary melanomas.

Ferrone CR, Ben Porat L, Panageas KS, Berwick M, Halpern AC, Patel A, Coit DG.

JAMA. 2005 Oct 5;294(13):1647-54.PMID: 16204664 [PubMed - indexed for MEDLINE]Related articlesFree article

Phosphorylated/activated HER2 as a marker of clinical resistance to single agent taxane chemotherapy for metastatic breast cancer.

Modi S, DiGiovanna MP, Lu Z, Moskowitz C, Panageas KS, Van Poznak C, Hudis CA, Norton L, Tan L, Stern DF, Carter D, Seidman AD.

Cancer Invest. 2005;23(6):483-7.PMID: 16203655 [PubMed - indexed for MEDLINE]Related articles

Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancer.

Hurria A, Hurria A, Brogan K, Panageas KS, Pearce C, Norton L, Jakubowski A, Howard J, Hudis C.

Drugs Aging. 2005;22(9):785-91.PMID: 16156682 [PubMed - indexed for MEDLINE]Related articles

Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane.

Fornier MN, Modi S, Panageas KS, Norton L, Hudis C.

Cancer. 2005 Oct 15;104(8):1575-9.PMID: 16134178 [PubMed - indexed for MEDLINE]Related articlesFree article

Change in cycle 1 to cycle 2 haematological counts predicts toxicity in older patients with breast cancer receiving adjuvant chemotherapy.

Hurria A, Brogan K, Panageas KS, Jakubowski A, Zauderer M, Pearce C, Norton L, Howard J, Hudis C.

Drugs Aging. 2005;22(8):709-15.PMID: 16060720 [PubMed - indexed for MEDLINE]Related articles

PTEN expression in melanoma: relationship with patient survival, Bcl-2 expression, and proliferation.

Mikhail M, Velazquez E, Shapiro R, Berman R, Pavlick A, Sorhaindo L, Spira J, Mir C, Panageas KS, Polsky D, Osman I.

Clin Cancer Res. 2005 Jul 15;11(14):5153-7.PMID: 16033830 [PubMed - indexed for MEDLINE]Related articlesFree article

Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy.

Hurria A, Brogan K, Panageas KS, Pearce C, Norton L, Jakubowski A, Zauderer M, Howard J, Hudis C.

Breast Cancer Res Treat. 2005 Jul;92(2):151-6.PMID: 15986124 [PubMed - indexed for MEDLINE]Related articles

A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane.

Modi S, Currie VE, Seidman AD, Bach AM, Panageas KS, Theodoulou M, Moasser MM, D'Andrea GM, Lake DE, Choi J, Norton L, Hudis CA.

Clin Breast Cancer. 2005 Apr;6(1):55-60.PMID: 15899073 [PubMed - indexed for MEDLINE]Related articles

Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study.

Hwu WJ, Lis E, Menell JH, Panageas KS, Lamb LA, Merrell J, Williams LJ, Krown SE, Chapman PB, Livingston PO, Wolchok JD, Houghton AN.

Cancer. 2005 Jun 15;103(12):2590-7.PMID: 15861414 [PubMed - indexed for MEDLINE]Related articlesFree article